Key result
Intravenous dipyridamole significantly increased the AH interval from 110 to 164 msec (p=0.002), demonstrating that endogenous adenosine affects AV nodal conduction under normoxic conditions.
Why the study?
Does intravenous dipyridamole affect atrioventricular nodal conduction and supraventricular tachycardia in humans?
Does intravenous dipyridamole affect atrioventricular nodal conduction and supraventricular tachycardia in humans?
Absolute Event Rate: 164% vs 110%
p-value: p=0.002
Intravenous dipyridamole significantly prolongs AV nodal conduction under normoxic conditions, an effect reversible by aminophylline, suggesting a role for endogenous adenosine in human AV nodal electrophysiology.
No takes yet. Share an insight, caveat, or question.
Endogenous adenosine may modulate AV nodal conduction in humans; challenges consensus on normoxic conditions and leaves open SVT implications.
Lerman et al. (1989) studied Supraventricular tachycardia (n=13). Intravenous dipyridamole vs. Baseline (control) was evaluated on AH interval at a constant atrial paced cycle length (p=0.002). Intravenous dipyridamole significantly increased the AH interval from 110 to 164 msec (p=0.002), demonstrating that endogenous adenosine affects AV nodal conduction under normoxic conditions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: